Keisuke Ae

2.1k total citations
80 papers, 1.3k citations indexed

About

Keisuke Ae is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Keisuke Ae has authored 80 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Pulmonary and Respiratory Medicine, 34 papers in Rheumatology and 25 papers in Oncology. Recurrent topics in Keisuke Ae's work include Sarcoma Diagnosis and Treatment (63 papers), Bone Tumor Diagnosis and Treatments (18 papers) and Vascular Tumors and Angiosarcomas (16 papers). Keisuke Ae is often cited by papers focused on Sarcoma Diagnosis and Treatment (63 papers), Bone Tumor Diagnosis and Treatments (18 papers) and Vascular Tumors and Angiosarcomas (16 papers). Keisuke Ae collaborates with scholars based in Japan, United States and Sweden. Keisuke Ae's co-authors include Seiichi Matsumoto, Taisuke Tanizawa, Atsushi Okawa, Takashi Shimoji, Tabu Gokita, Shingo Sato, Shu Takeda, Yuki Funauchi, Keiko Hayakawa and Kenichi Shinomiya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Keisuke Ae

72 papers receiving 1.3k citations

Peers

Keisuke Ae

PRM

ONCOL

RHEUM

Miklós Szendrői Hungary

Matthias Kevric Germany

Marie‐José Terrier‐Lacombe France

D. C. Mangham United Kingdom

Kenichiro Hamada Japan

Tomoya Matsunobu Japan

Angelica Zin Italy

Yvonne M.H. Versleijen‐Jonkers Netherlands

Josephine Issakov Israel

Mitsunori Kaya Japan

Miklós Szendrői Hungary

Keisuke Ae

543 ×0.9

PRM

330 ×0.8

ONCOL

348 ×0.9

413 ×1.2

RHEUM

222 ×1.1

Citations per year, relative to Keisuke Ae Keisuke Ae (= 1×) peers Miklós Szendrői

Countries citing papers authored by Keisuke Ae

Since Specialization

Citations

This map shows the geographic impact of Keisuke Ae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Ae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Ae more than expected).

Fields of papers citing papers by Keisuke Ae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Ae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Ae. The network helps show where Keisuke Ae may publish in the future.

Co-authorship network of co-authors of Keisuke Ae

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Ae. A scholar is included among the top collaborators of Keisuke Ae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Ae. Keisuke Ae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Machinami, Rikuo, Seiichi Matsumoto, Keisuke Ae, et al.. (2024). The association between CD34 expression status and the clinicopathological behavior of dedifferentiated liposarcoma. Pathology - Research and Practice. 260. 155376–155376.

Takagi, Satoshi, Sumie Koike, Miho Takami, et al.. (2024). Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma. Oncogene. 44(12). 794–804.

Iwata, Shintaro, Masanori Saito, Makoto Nakagawa, et al.. (2023). Hip Transposition Can Provide Early Walking Function After Periacetabular Tumor Resection: A Multicenter Study. Clinical Orthopaedics and Related Research. 481(12). 2406–2416. 4 indexed citations

Kito, Munehisa, Keisuke Ae, Masanori Okamoto, et al.. (2023). Clinical Outcome of Low-Grade Myofibroblastic Sarcoma in Japan: A Multicenter Study from the Japanese Musculoskeletal Oncology Group. Cancers. 15(8). 2314–2314. 6 indexed citations

Takemoto, Ai, Satoshi Takagi, Nobuhiko Gyobu, et al.. (2022). Targeting Podoplanin for the Treatment of Osteosarcoma. Clinical Cancer Research. 28(12). 2633–2645. 19 indexed citations

Takagi, Satoshi, Sumie Koike, Ai Takemoto, et al.. (2021). Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis. Oncogene. 40(36). 5548–5558. 33 indexed citations

Sato, Yasuyoshi, Kenji Nakano, Xiaofei Wang, et al.. (2021). Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma. Cancers. 13(24). 6266–6266. 10 indexed citations

Machinami, Rikuo, Seiichi Matsumoto, Hiroaki Kanda, et al.. (2021). Prognostic value of CD34 expression status in patients with myxofibrosarcomas and undifferentiated pleomorphic sarcomas. Scientific Reports. 11(1). 15494–15494. 4 indexed citations

Nakano, Kenji, Keiko Hayakawa, Yuki Funauchi, et al.. (2020). Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Molecular and Clinical Oncology. 14(1). 13–13. 6 indexed citations

10.

Tanaka, Miwa, Mizuki Homme, Yukari Yamazaki, et al.. (2020). Cooperation between SS18-SSX1 and miR-214 in Synovial Sarcoma Development and Progression. Cancers. 12(2). 324–324. 12 indexed citations

11.

Tanaka, Miwa, Yukari Yamazaki, Kyoko Yamashita, et al.. (2020). Identification of Novel Fusion Genes in Bone and Soft Tissue Sarcoma and Their Implication in the Generation of a Mouse Model. Cancers. 12(9). 2345–2345. 8 indexed citations

12.

Nakano, Kenji, Yuki Funauchi, Keiko Hayakawa, et al.. (2019). Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders. Journal of Clinical Medicine. 8(1). 60–60. 11 indexed citations

13.

Kito, Munehisa, Keisuke Ae, Tabu Gokita, et al.. (2019). Risk factor for wound complications following wide resection of soft tissue sarcoma in the adductor compartment of the thigh. Japanese Journal of Clinical Oncology. 49(10). 932–937. 7 indexed citations

14.

Nakano, Kenji, Keisuke Ae, Seiichi Matsumoto, & Shunji Takahashi. (2019). The VAC regimen for adult rhabdomyosarcoma: Differences between adolescent/young adult and older patients. Asia-Pacific Journal of Clinical Oncology. 16(2). e47–e52. 3 indexed citations

15.

Nishida, Yoshihiro, Akira Kawai, Junya Toguchida, et al.. (2019). Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan. International Journal of Clinical Oncology. 24(11). 1498–1505. 5 indexed citations

16.

Koike, Hiroshi, Yoshihiro Nishida, Kei Kohno, et al.. (2018). Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study. Human Pathology. 84. 155–163. 21 indexed citations

17.

Fujibuchi, Taketsugu, Seiichi Matsumoto, Takashi Shimoji, et al.. (2014). New endoprosthesis suspension method with polypropylene monofilament knitted mesh after resection of bone tumors in proximal humerus. Journal of Shoulder and Elbow Surgery. 24(6). 882–888. 16 indexed citations

18.

Ae, Keisuke, Seiichi Matsumoto, Takashi Shimoji, et al.. (2012). Long-term results from use of pasteurized bone. Journal of Orthopaedic Science. 17(5). 605–613. 12 indexed citations

19.

Matsumoto, Seiichi, et al.. (2011). What Are Risk Factors for Local Recurrence of Deep High-grade Soft-tissue Sarcomas?. Clinical Orthopaedics and Related Research. 470(3). 700–705. 29 indexed citations

20.

Matsumoto, Seiichi, Jun Manabe, Hiroshi Kuroda, et al.. (2009). Surgical margin for local recurrence of soft tissue sarcoma. Journal of Orthopaedic Science. 83(1). 22–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact